Follow‐up of Chinese liver transplant recipients in Hong Kong
Sheung Tat Fan, Haibo Wang, Banny K. Lam – 27 April 2009 – The outcome of liver transplantation in China remains speculative. From 1998 to 2007, 177 adult Hong Kong patients underwent liver transplantation in China and were subsequently followed up at Queen Mary Hospital, Hong Kong. One hundred six (59.9%) patients had hepatocellular carcinoma (HCC). The grafts were probably derived from uncontrolled non–heart‐beating donors. The 1‐month mortality rate was 4.0%. The 1‐, 3‐, and 5‐year overall survival rates were 73.9%, 59.0%, and 53.9%, respectively.